The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of pima indians
Open accessAbstract
BACKGROUND: The relative roles of obesity, insulin resistance, insulin secretory dysfunction, and excess hepatic glucose production in the development of non-insulin-dependent diabetes mellitus (NIDDM) are controversial. We conducted a prospective study to determine which of these factors predicted the development of the disease in a group of Pima Indians. METHODS: A body-composition assessment, oral and intravenous glucose-tolerance tests, and a hyperinsulinemic--euglycemic clamp study were performed in 200 non-diabetic Pima Indians (87 women and 113 men; mean [+/- SD] age, 26 +/- 6 years). The subjects were followed yearly thereafter for an average of 5.3 years. RESULTS: Diabetes developed in 38 subjects during follow-up. Obesity, insulin resistance (independent of obesity), and low acute plasma insulin response to intravenous glucose (with the degree of obesity and insulin resistance taken into account) were predictors of NIDDM: The six-year cumulative incidence of NIDDM was 39 percent in persons with values below the median for both insulin action and acute insulin response, 27 percent in those with values below the median for insulin action but above that for acute insulin response, 13 percent in those with values above the median for insulin action and below that for acute insulin response, and 0 in those with values originally above the median for both characteristics. CONCLUSIONS: Insulin resistance is a major risk factor for the development of NIDDM: A low acute insulin response to glucose is an additional but weaker risk factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, progressive β-cell failure is required and ultimately responsible for type 2 diabetes to become fully manifest ( 1 , 34 , 35 , 37 , 38 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicating impaired beta-cell adaptation [108, 109, 110, 111, 112, 113, 114].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. D. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,680
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158
Ohlson, L., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,143
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G. I., Zouali, H., Lesage, S., Velho, G., Iris, F., Passa, P., et al. (1992) · Nature · doi:10.1038/356721a0 · Cited by 604
Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578
Self-citationImpaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578
Self-citationBogardus, C., Lillioja, S., Howard, B. V., Reaven, G. M., & Mott, D. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111533 · Cited by 397
Self-citationHaffner, S. M., Stern, M. P., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diabetes.39.3.283 · Cited by 397
Haffner, S. M., D, M. P. S. M., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diab.39.3.283 · Cited by 397
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
Kadowaki, T., Miyake, Y., Hagura, R., Akanuma, Y., Kajinuma, H., Kuzuya, N., Takaku, F., & Kosáka, K. (1984) · Diabetologia · doi:10.1007/bf00252262 · Cited by 315
Leahy, J. L., Cooper, H. E., Deal, D. A., & Weir, G. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112389 · Cited by 289
The ten-year follow-up of the Bedford Survey (1962?1972): Glucose tolerance and diabetes
KEEN, H., Jarrett, R. J., & McCartney, P. (1982) · Diabetologia · doi:10.1007/bf00254832 · Cited by 282
Ohlson, L. O., Larsson, B., Svardsudd, K., et al. (1985) · Diabetes · doi:10.2337/diabetes.34.10.1055 · Cited by 245
Risk Factors for NIDDM in White Population: Paris Prospective Study
Charles, M.-A. A., Fontbonne, A., Thibult, N., Warnet, J., Rosselin, G., & Eschwège, É. (1991) · Diabetes · doi:10.2337/diab.40.7.796 · Cited by 241
Plasma Insulin Response Among Nauruans: Prediction of Deterioration in Glucose Tolerance Over 6 Yr
Sicree, R. A., Zimmet, P., King, H. O. M., & Coventry, J. S. (1987) · Diabetes · doi:10.2337/diab.36.2.179 · Cited by 232
Obesity and insulin resistance: Lessons learned from the Pima indians
Lillioja, S., & Bogardus, C. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040508 · Cited by 203
Self-citationBergstrom, R. W., Newell-Morris, L. L., Leonetti, D. L., Shuman, W. P., Wahl, P. W., & Fujimoto, W. Y. (1990) · Diabetes · doi:10.2337/diacare.39.1.104 · Cited by 194
Glucose Disposal is Not Proportional to Plasma Glucose Level in Man
Best, J., Taborsky, G., Halter, J., & Porte, D. (1981) · Diabetes · doi:10.2337/diab.30.10.847 · Cited by 188
Aspects of the Pathogenesis of Type 2 Diabetes*
Efendić, S., Luft, R., & Wajngot, A. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-3-395 · Cited by 153
Kosáka, K., Hagura, R., & Kuzuya, T. (1977) · Diabetes · doi:10.2337/diab.26.10.944 · Cited by 152
Lillioja, S., Nyomba, B. L. G., Saad, M. F., Ferraro, R. T., CASTILLO, C., Bennett, P. H., & Bogardus, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-866 · Cited by 136
Self-citationMaturity‐onset diabetes of the young (MODY)
Fajans, S. S. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050705 · Cited by 129
Lundgren, H., Bengtsson, C., Blohmé, G., Lapidus, L., & Waldenström, J. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01415.x · Cited by 103
The Effect of Rate and Dose of Glucose Infusion on the Acute Insulin Response in Man
CHEN, M., & Porte, D. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-6-1168 · Cited by 75
Risk factors for NIDDM in white population. Paris prospective study
Charles, M.-A. A., Fontbonne, A., Thibult, N., et al. (1991) · Diabetes · doi:10.2337/diabetes.40.7.796 · Cited by 74
Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr
Sicree, R. A., Zimmet, P., King, H. O., et al. (1987) · Diabetes · doi:10.2337/diabetes.36.2.179 · Cited by 67
Insulin Action in Black Americans With NIDDM
Banerji, M. A., & Lebovitz, H. E. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1295 · Cited by 62
Glucose disposal is not proportional to plasma glucose level in man
Best, J. D., Taborsky, G., Halter, J. B., et al. (1981) · Diabetes · doi:10.2337/diabetes.30.10.847 · Cited by 40
Groop, L., Miettinen, A., Groop, P. H., Meri, S., Koskimies, S., & Bottazzo, G. F. (1988) · Diabetes · doi:10.2337/diabetes.37.1.99 · Cited by 28
Research works printed but not linked: 2
- 1985, World Health Organ Tech Rep Ser, 727, 9
- Gottesman I, 1983, Am J Physiol, 244, E632
Cited by
Sorted by citations
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Metadata
- Authors
- Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1993-12-30
- Volume
- 329
- Issue
- 27
- Pages
- 1988-1992
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2334309509
- Cited by
- 1,508
- References
- 27
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 30 · 2023: 22 · 2022: 34 · 2021: 38 · 2020: 39 · 2019: 37 · 2018: 40 · 2017: 30 · 2016: 40 · 2015: 52 · 2014: 44 · 2013: 45 · 2012: 44
- FWCI
- 30.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin resistance, type 2 diabetes, Pima Indians, obesity, acute insulin response, hepatic glucose production, insulin action, diabetes risk factors, hyperinsulinemic-euglycemic clamp, glucose tolerance
- MeSH terms
- Insulin Secretion, Adult, Arizona, Body Composition, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glucose, Glucose Tolerance Test, Humans, Indians, North American, Insulin, Insulin Resistance, Liver, Male, Obesity, Prospective Studies, Risk Factors, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
